Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Sales, Receipts, and Operating Revenues

QFR101385USNOincome spendingFree tier

Series IDQFR101385USNO
UnitsMillions of Dollars
FrequencyQuarterly
Categoryincome spending
Latest observation2026-04-01
HistoryPoint-in-time: every value as first published plus each revision, so backtests see only what was known on the day

Latest reading

The latest Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: Net Sales, Receipts, and Operating Revenues observation, for 2026-04-01, is 202,912 Millions of Dollars, up from 190,494 for 2026-01-01. It has not been revised since it was first published. 37.9% of observations in this history were revised after first release.

Latest observation2026-04-01
Latest value202,912 Millions of Dollars
Previous190,494 (2026-01-01)
Change12,418 (+6.5%)
First published value202,912
Last release2026-09-08
Vintages stored37
Observations103
Largest revision (5 years)2025-07-01: 184,710 → 192,551

Get it in Python

import finzdata as yf
df = yf.Client().macro("QFR101385USNO")
df.tail()

Or chart it live on FinzData Explore.

Get a free API keySee history bundlesDownload free samples

Related income spending series

Related searches